Johnny Yang

1.4k citations

30 papers · 1.1k indexed · h-index 15

Impact in

Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer-related Molecular Pathways

Papers in ⓘ

Oncology 15
- Drug Transport and Resistance Mechanisms 8
- HER2/EGFR in Cancer Research 2
- Cancer-related Molecular Pathways 2
Family Practice 1

Co-authors: Chenxi Xia (1 shared paper)R B Kim (1 shared paper)Vincent H.L. Lee (3 shared papers)Hideo UEDA (2 shared papers)Vincent H. L. Lee (2 shared papers)Jasmine Davda (1 shared paper)Vinod Labhasetwar (1 shared paper)Mohamed G. Qaddoumi (1 shared paper)
Journals: Pharmaceutical Research (3 papers)PLoS ONE (2 papers)Molecular Cancer Therapeutics (1 paper)Molecular Oncology (1 paper)Plastic & Reconstructive Surgery (1 paper)
Partner nations: United States Japan India

In The Last Decade

Johnny Yang

29 papers receiving 1.0k citations

Peers

Countries citing papers authored by Johnny Yang

Since Specialization

Citations

This map shows the geographic impact of Johnny Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnny Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnny Yang more than expected).

Fields of papers citing papers by Johnny Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johnny Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnny Yang. The network helps show where Johnny Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Johnny Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Johnny Yang Line = papers co-authored together Johnny Yang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Drug Transporters in Drug Efficacy and Toxicity The Annual Review of Pharmacology and Toxicology ·M.K. DeGorter, Chenxi Xia, Johnny Yang, R B Kim	2011	272
2	The Characteristics and Mechanisms of Uptake of PLGA Nanoparticles in Rabbit Conjunctival Epithelial Cell Layers Pharmaceutical Research ·Mohamed G. Qaddoumi, Hideo UEDA, Johnny Yang, Jasmine Davda, Vinod Labhasetwar, Vincent H.L. Lee	2004	195
3	Current Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Antibody-Drug Conjugates: An Industry White Paper Drug Metabolism and Disposition ·Eugenia Kraynov, Ajith V. Kamath, Markus Walles, Edit Tarcsa, Antoine Deslandes, Ramaswamy A. Iyer, Amita Datta‐Mannan, P. Sriraman, Michaela Bairlein, Johnny Yang, Michael E. Barfield, Guangqing Xiao, Enrique Escandón, W. Wang, Dan A. Rock, Nagendra Chemuturi, David J. Moore	2015	70
4	TAK-960, a Novel, Orally Available, Selective Inhibitor of Polo-Like Kinase 1, Shows Broad-spectrum Preclinical Antitumor Activity in Multiple Dosing Regimens Molecular Cancer Therapeutics ·Yuichi Hikichi, Kohei Honda, Kouki Hikami, Hitoshi Miyashita, Isao Kaieda, Saomi Murai, Noriko Uchiyama, Maki Hasegawa, Tomohiro Kawamoto, Takashi Sato, Takashi Ichikawa, Sheldon Cao, Zhe Nie, Lilly Zhang, Johnny Yang, Keisuke Kuida, Erik Kupperman	2011	64
5	Role of P-Glycoprotein in Restricting Propranolol Transport in Cultured Rabbit Conjunctival Epithelial Cell Layers Pharmaceutical Research ·Johnny Yang, Kwang-Jin Kim, Vincent H. L. Lee	2000	55
6	Existence of a p-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells. PubMed ·Pratik Saha, Johnny Yang, Vincent H. L. Lee	1998	54
7	Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO‐dependent mechanism International Journal of Cancer ·Kevin R. Kelly, Steffan T. Nawrocki, Claudia M. Espitia, Mengkun Zhang, Johnny Yang, Swaminathan P. Iyer, Jeffrey Ecsedy, Francis J. Giles, Jennifer S. Carew	2012	44
8	P-Glycoprotein and Breast Cancer Resistance Protein Affect Disposition of Tandutinib, A Tyrosine Kinase Inhibitor Drug Metabolism Letters ·Johnny Yang, Mark Milton, Shaoxia Yu, Mingxiang Liao, Ning Liu, Jingtao Wu, Liang‐Shang Gan, Suresh K. Balani, Frank W. Lee, Shimoga R. Prakash, Cindy Q. Xia	2010	43
9	Breast cancer resistance protein in pharmacokinetics and drug–drug interactions Expert Opinion on Drug Metabolism & Toxicology ·Cindy Q. Xia, Johnny Yang, Liang‐Shang Gan	2005	39
10	Meeting future challenges in topical ocular drug delivery: Journal of Controlled Release ·Johnny Yang, Hideo UEDA, Kwang-Jin Kim, Vincent H.L. Lee	2000	30
11	Multidrug Resistance Protein 1 (MRP1) in Rabbit Conjunctival Epithelial Cells: Its Effect on Drug Efflux and Its Regulation by Adenoviral Infection Pharmaceutical Research ·Johnny Yang, David K. Ann, Ram Kannan, Vincent H.L. Lee	2007	21
12	A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo PLoS ONE ·Melissa Gallery, Julie Zhang, Daniel P. Bradley, Pamela P. Brauer, Donna Cvet, Jose Estevam, Hadi Danaee, Edward Greenfield, Ping Li, Mark Manfredi, Huay-Keng Loke, Claudia Rabino, Brad Stringer, Mark J. Williamson, Tim Wyant, Johnny Yang, Qing Zhu, Adnan O. Abu‐Yousif, O. Petter Veiby	2018	20
13	Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinase Cancer Chemotherapy and Pharmacology ·Santhosh Palani, Mayankbhai Patel, Jessica J. Huck, Mengkun Zhang, Suresh K. Balani, Johnny Yang, Susan Chen, Jerome T. Mettetal, Mark Manfredi, Wen Chyi Shyu, Jeffrey Ecsedy, Arijit Chakravarty	2013	19
14	Examining the context, logistics, and outcomes of food prescription programs: A scoping review Research in Social and Administrative Pharmacy ·Anne Cafer, Meagen Rosenthal, Parker Smith, Danielle McGrew, Kaustuv Bhattacharya, Yiran Rong, Monika Salkar, Johnny Yang, Jasmine Nguyen, Austin Arnold	2022	17
15	Preclinical Drug Metabolism and Pharmacokinetics, and Prediction of Human Pharmacokinetics and Efficacious Dose of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237) Drug Metabolism Letters ·Johnny Yang, L. Yu, Arijit Chakravarty, Chuang Lu, Cindy Q. Xia, Susan Chen, Sandeep Pusalkar, Mengkun Zhang, Jeffrey Ecsedy, Mark Manfredi, Jing‐Tao Wu, Wen Chyi Shyu, Suresh K. Balani	2014	16
16	Synthesis of a new inhibitor of breast cancer resistance protein with significantly improved pharmacokinetic profiles Bioorganic & Medicinal Chemistry Letters ·Yuexian Li, Jiyeon Woo, Jessica Chmielecki, Cindy Q. Xia, Mingxiang Liao, Bei-Ching Chuang, Johnny Yang, Miao Y. Guan, Mihaela Plesescu, Shimoga R. Prakash	2015	14
17	Dose Schedule Optimization and the Pharmacokinetic Driver of Neutropenia PLoS ONE ·Mayankbhai Patel, Santhosh Palani, Arijit Chakravarty, Johnny Yang, Wen Chyi Shyu, Jerome T. Mettetal	2014	13
18	Changing Role of PET/CT in Cancer Care With a Focus on Radiotherapy Cureus ·Srinivasan Vijayakumar, Johnny Yang, Mary R Nittala, Alexander E Velazquez, Brandon L Huddleston, Nickhil A Rugnath, Neha Adari, Abhay K Yajurvedi, Abhinav Komanduri, Claus Chunli Yang, William N Duggar, William P Berlin, Richard Duszak, Vani Vijayakumar	2022	12
19	QSAR Analysis of Polyamine Transport Inhibitors in L1210 Cells Journal of drug targeting ·Cindy Q. Xia, Johnny Yang, Shijun Ren, Eric J. Lien	1998	11
20	An Overview of the Use of Precision Population Medicine in Cancer Care: First of a Series Cureus ·Johnny Yang, Mary R Nittala, Alexander E Velazquez, Vedanth Buddala, Srinivasan Vijayakumar	2023	9

About Johnny Yang

Johnny Yang is a scholar working on Oncology, Family Practice, Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health and Cell Biology, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Microtubule and mitosis dynamics (4 papers), Cancer Genomics and Diagnostics (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), HER2/EGFR in Cancer Research (2 papers), Cancer-related Molecular Pathways (2 papers), Pregnancy and Medication Impact (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Pharmaceutical Science (150 citations), Oncology (502 citations), Pharmacology (83 citations), Biomaterials (117 citations) and Pediatrics, Perinatology and Child Health (156 citations). Johnny Yang has collaborated with scholars based in United States, Japan and India. Frequent co-authors include Chenxi Xia, R B Kim, Vincent H.L. Lee, Hideo UEDA, Vincent H. L. Lee, Jasmine Davda, Vinod Labhasetwar, Mohamed G. Qaddoumi, Cindy Q. Xia and Pratik Saha. Their work appears in journals such as Pharmaceutical Research, PLoS ONE, Molecular Cancer Therapeutics, Molecular Oncology and Plastic & Reconstructive Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact